Article
Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.
Annals of the rheumatic diseases - 1 Aug 2015
Parker Ben, Urowitz Murray B, Gladman Dafna D, Lunt Mark, Donn Rachelle, Bae Sang-Cheol, Sanchez-Guerrero Jorge, Romero-Diaz Juanita, Gordon Caroline, Wallace Daniel J, Clarke Ann E, Bernatsky Sasha, Ginzler Ellen M, Isenberg David A, Rahman Anisur, Merrill Joan T, Alarcón Graciela S, Fessler Barri J, Fortin Paul R, Hanly John G, Petri Michelle, Steinsson Kristjan, Dooley Mary Anne, Manzi Susan, Khamashta Munther A, Ramsey-Goldman Rosalind, Zoma Asad A, Sturfelt Gunnar K, Nived Ola, Aranow Cynthia, Mackay Meggan, Ramos-Casals Manuel, van Vollenhoven Ronald F, Kalunian Kenneth C, Ruiz-Irastorza Guillermo, Lim S Sam, Kamen Diane L, Peschken Christine A, Inanc Murat, Bruce Ian N
Abstract excerpt
BACKGROUND: The metabolic syndrome (MetS) may contribute to the increased cardiovascular risk in systemic lupus erythematosus (SLE). We examined the association between MetS and disease activity, disease phenotype and corticosteroid exposure over time in patients with SLE. METHODS: Recently diagnosed (<15 months) patients with SLE from 30 centres across 11 countries were enrolled into the Systemic Lupus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.